Patient advisory panel synthesis

An MVP, or minimum viable product, is the smallest version that your users can actually work with. It is not a cheap version of the full solution. It is a test, built to answer the questions that decide whether the rest is worth building.

1. Pick the riskiest assumption. Here: will hospital quality improvement teams use it to solve "panel feedback is summarized without preserving minority experiences"?
2. Build only what tests it. One team, one use case, a few core modules. People do the rest by hand for now.
3. Run a paid pilot. Agree the acceptance criteria, input limits and reviewer responsibilities before starting.
4. Measure, then decide. Track traceable themes and participant agreement. Then expand, change course or stop, with evidence instead of opinions.

MVP scope for this solution. Costed pilot: Qualitative service research with consent. Start with one buyer organization and a bounded set of representative inputs. Implement the first two modules: separate distinct experiences; link quotes. Support the third task through an assisted review queue: flag contradictory feedback. Handle the remaining required functions manually until validated. Include input upload, source references, user correction, a reviewer approval step and export of patient advisory evidence brief. Authentication, account isolation, deletion controls and basic operational logging are included. Specialized production certification, live write integrations and broader rollout are not included unless explicitly stated.

After the MVP. After paying customers repeatedly accept patient advisory evidence brief, automate draft clarification questions; track staff responses; export participant summaries. Add one tested read integration, reusable customer configuration and scheduled repeat delivery. Increase supported formats or teams only when evaluation cases and reviewer capacity cover the new scope. Qualitative service research with consent.

What the build depends on. A clear research protocol, source access, citation tracking and qualified interpretation. Interview work also needs relevant participants and consent management. Obtain representative authorized inputs, an agreed review rubric and a buyer-side owner. Specific scope: Qualitative service research with consent.

Pricing to test

Test USD 750-3,000 for one tightly bounded research question and evidence pack. Participant recruitment, specialist review and licensed data are separately scoped. Repeat tracking can become a retainer. Prices are hypotheses. For this buyer, package the first sale around synthesize one advisory session and the defined patient advisory evidence brief. Record actual review effort before offering a recurring allowance. The commercial pilot fee is distinct from the platform development budget.

Message to test

Preserve dissenting patient experiences alongside dominant themes. Demonstrate the result with synthesize one advisory session for hospital quality improvement teams. Use a concrete before-and-after example without promising unmeasured savings.

Where to find buyers

Patient engagement networks and quality consultants

Lead magnet

Synthesize one advisory session

The first 30 days

1. Week 1: interview five prospective buyers from hospital quality improvement teams and inspect how they handle panel feedback is summarized without preserving minority experiences.
2. Week 2: prepare synthesize one advisory session using authorized or synthetic material.
3. Week 3: share the demonstration through patient engagement networks and quality consultants and seek one bounded paid pilot.
4. Week 4: measure traceable themes and participant agreement, review delivery effort and ask for a repeat purchase. This is a validation schedule, not a promise that the full product can be built in thirty days.

Paid pilot

Agree the acceptance criteria, input limits and reviewer responsibilities before starting. Run synthesize one advisory session and deliver patient advisory evidence brief. Compare traceable themes and participant agreement with the buyer's current process on comparable cases; include corrections, missed issues and reviewer time. Seek payment and repeat use. Stop or revise the scope if data access, accuracy or unit economics fail.

Success metrics

Traceable themes and participant agreement

Retention and expansion

Build repeat use around patient advisory evidence brief. Save approved configurations and review decisions with permission, revisit unresolved exceptions and show progress on traceable themes and participant agreement. Offer a recurring volume allowance after repeat demand; expand to adjacent tasks only when the buyer asks and delivery quality remains acceptable.

Why clients would pick it

Niche research protocols, credible researcher relationships and a rights-cleared evidence archive with consistent interpretation methods. For this concept, accumulate permissioned examples and reviewer corrections around preserve dissenting patient experiences alongside dominant themes. The durable asset is reliable task-specific execution and trusted customer configuration, not access to a general-purpose AI model.

Alternatives and positioning

Research consultants, internal analysts, literature databases and general search or summarization tools. Position this concept around preserve dissenting patient experiences alongside dominant themes. Compare it against the customer's current process on the same representative task. This is proposed differentiation; no exhaustive competitor study or uniqueness claim has been established.

Main delivery costs

Researcher time, source access, participant recruitment, transcription, evidence coding, expert review and report revisions. Initial validation additionally budgets for participant facilitation and privacy review. Track model usage, storage, reviewer minutes, exception handling and customer support per accepted deliverable.